The Bon Secours Hospital, Cork is a private hospital in Cork, Ireland. The hospital is part of Bon Secours Mercy Health. This includes sister hospitals in Dublin, Galway, Limerick and Tralee. The hospital has over 18,000 admissions and 29,000 outpatients attendances per year.

There are 343 beds in Bon Secours Hospital.

During the past decade, Bon Secours Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bon Secours Hospital" #1 sponsor was "Cancer Trials Ireland" with 14 trials, followed by "Pfizer" with 6 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "ImmunoGen, Inc." with 2 trials sponsored and "Institut de Recherches Internationales Servier" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bon Secours Hospital" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Bon Secours Hospital" are "Breast Cancer" (9 trials), "Ovarian Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Fallopian Tube Cancer" (3 trials) and "Advanced Colorectal Cancer" (2 trials). Many other conditions were trialed in "Bon Secours Hospital" in a lesser frequency.

Most popular intervention types in "Bon Secours Hospital" are "Drug" (25 trials), "Other" (7 trials), "Biological" (4 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Letrozole" (3 trials), "Quality-of-Life Assessment" (3 trials) and "Anastrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Hospital" are 21 trials for "Female" genders, 15 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bon Secours Hospital". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Bon Secours Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Bon Secours Hospital has several departments that took part in Clinical trials: "Radiology Department" - 2 trials